Striking a balance between ADC safety and efficacy
Year: 2025
Type: article
Abstract: “Continued efforts to educate both clinicians and patients, alongside the adoption of proactive safety management protocols, are essential to advancing the safe and effective use of ADCs in cancer treatments.”On October 9, 2024, Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, spoke to Rakesh Dixit, Cofounder, President and CSO of Regio Biosciences, CEO of Bionavigen, and CSO of Tmab Therapeutics, about the application of ADCs in cancer treatment. This article is based on that interview.
Source: Bioconjugation Insights
Author: Rakesh Dixit
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4417334207
FWCI:
Cites:
Cited by:
Related to: